Detalles de la búsqueda
1.
Impact of high on-treatment platelet reactivity on outcomes following PCI in patients on hemodialysis: An ADAPT-DES substudy.
Catheter Cardiovasc Interv
; 96(4): 793-801, 2020 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31721430
2.
Adverse events in patients with high platelet reactivity following successful chronic total occlusion PCI: The Assessment of Dual AntiPlatelet Therapy with Drug-Eluting Stents (ADAPT-DES) study.
Am Heart J
; 211: 68-76, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30897527
3.
Impact of high on-aspirin platelet reactivity on outcomes following successful percutaneous coronary intervention with drug-eluting stents.
Am Heart J
; 205: 77-86, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30196181
4.
Prediction of 1-year mortality and impact of bivalirudin therapy according to level of baseline risk: A patient-level pooled analysis from three randomized trials.
Catheter Cardiovasc Interv
; 87(3): 391-400, 2016 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26624854
5.
Relationship between intravascular ultrasound guidance and clinical outcomes after drug-eluting stents: the assessment of dual antiplatelet therapy with drug-eluting stents (ADAPT-DES) study.
Circulation
; 129(4): 463-70, 2014 Jan 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-24281330
6.
Predictors and impact of target vessel revascularization after stent implantation for acute ST-segment elevation myocardial infarction: lessons from HORIZONS-AMI.
Am Heart J
; 169(2): 242-8, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25641533
7.
Sex-based differences in bleeding and long term adverse events after percutaneous coronary intervention for acute myocardial infarction: three year results from the HORIZONS-AMI trial.
Catheter Cardiovasc Interv
; 85(3): 359-68, 2015 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25115966
8.
Contrast-induced acute kidney injury after primary percutaneous coronary intervention: results from the HORIZONS-AMI substudy.
Eur Heart J
; 35(23): 1533-40, 2014 Jun 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-24603308
9.
Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study.
Lancet
; 382(9892): 614-23, 2013 Aug 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-23890998
10.
New generation drug-eluting stents for ST-elevation myocardial infarction: a new paradigm for safety.
Catheter Cardiovasc Interv
; 84(6): 955-62, 2014 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-24174334
11.
Very late hazard with stenting versus balloon angioplasty for ST-elevation myocardial infarction: a 16-year single-center experience.
J Interv Cardiol
; 27(1): 21-8, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24372979
12.
D-dimer levels predict ischemic and hemorrhagic outcomes after acute myocardial infarction: a HORIZONS-AMI biomarker substudy.
J Thromb Thrombolysis
; 37(2): 155-64, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-23925451
13.
Are adverse events following an invasive strategy in patients with non-ST-segment elevation acute coronary syndromes more frequent at US sites versus non-US sites? Analysis from the ACUITY trial.
Catheter Cardiovasc Interv
; 82(4): E365-74, 2013 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22887494
14.
Impact of advanced age on the safety and effectiveness of paclitaxel-eluting stent implantation in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty: The HORIZONS-AMI trial.
Catheter Cardiovasc Interv
; 82(6): 869-77, 2013 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-23359554
15.
Coronary reperfusion and clinical outcomes after thrombus aspiration during primary percutaneous coronary intervention: findings from the HORIZONS-AMI trial.
Catheter Cardiovasc Interv
; 82(4): 594-601, 2013 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23074151
16.
Relationship between biomarkers and subsequent bleeding risk in ST-segment elevation myocardial infarction patients treated with paclitaxel-eluting stents: a HORIZONS-AMI substudy.
J Thromb Thrombolysis
; 35(2): 200-8, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23212802
17.
On-Treatment Platelet Reactivity and Ischemic Outcomes in Patients With Diabetes Mellitus: Two-Year Results From ADAPT-DES.
J Am Heart Assoc
; 12(1): e026482, 2023 01 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36565189
18.
Frequency and predictors of stent thrombosis after percutaneous coronary intervention in acute myocardial infarction.
Circulation
; 123(16): 1745-56, 2011 Apr 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-21482968
19.
Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial.
Lancet
; 377(9784): 2193-204, 2011 Jun 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-21665265
20.
Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction.
N Engl J Med
; 360(19): 1946-59, 2009 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-19420364